Targeting mitochondria and related protein suggest new therapeutic strategy for treating ALS
Researchers at Nagoya University in Japan have discovered a receptor, sigma-1 receptor, and a protein, ATAD3A, that are associated with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. Since there ...
Apr 26, 2023
0
2